Prof. Dr. Saadettin Kılıçkap

Determining the Current Situation of Geriatric Oncology in Turkey: A Survey of Medical Oncologists

Journal of Oncological Sciences, 2021

DOI 10.37047/jos.2020-80824 Frei zugänglicher VolltextQuelle: OpenAlex

European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer

Annals of Oncology, 2021

DOI 10.1016/j.annonc.2021.11.013 PMID 34861371 133 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Initiation of Chemosaturation With Percutaneous Hepatic Perfusion Program in Interventional Radiology Department

Cureus, 2021

DOI 10.7759/cureus.17880 PMID 34660079 Frei zugänglicher VolltextQuelle: OpenAlex

Thirty-day mortality rates after immunotherapy initiation

Immunotherapy, 2021

DOI 10.2217/imt-2021-0082 PMID 34676791 2 Zitationen (Europe PMC) Quelle: Europe PMC

Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab

International Journal of Clinical Oncology, 2021

DOI 10.1007/s10147-021-01936-6 PMID 34023933 14 Zitationen (Europe PMC) Quelle: ORCID

Merkel cell carcinoma in Turkey: A multicentric study

Journal of Cancer Research and Therapeutics, 2021

DOI 10.4103/jcrt.jcrt_950_19 PMID 34916389 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Lower prognostic nutritional index is associated with poorer survival in patients receiving immune checkpoint inhibitors

Biomarkers in medicine, 2021

DOI 10.2217/bmm-2020-0674 PMID 34397271 8 Zitationen (Europe PMC) Quelle: Europe PMC

Antibody Responses to COVID-19 Vaccination in Cancer: A Systematic Review

Frontiers in Oncology, 2021

DOI 10.3389/fonc.2021.759108 PMID 34804957 25 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Assessment of adherence to cancer-associated venous thromboembolism guideline and pharmacist’s impact on anticoagulant therapy

Supportive Care in Cancer, 2021

DOI 10.1007/s00520-020-05669-6 PMID 32776163 9 Zitationen (Europe PMC) Quelle: ORCID

Blood based biomarkers as predictive factors for hyperprogression

Research Square, 2021

DOI 10.21203/rs.3.rs-991928/v1 Frei zugänglicher VolltextQuelle: ORCID

Chemoimmunotherapy for the salvage treatment of Ewing sarcoma: A case report

Journal of Oncology Pharmacy Practice, 2021

DOI 10.1177/1078155220965677 PMID 33070764 7 Zitationen (Europe PMC) Quelle: ORCID

Clinical features and outcomes of COVID-19 in patients with solid tumors: Turkish National Registry Data

International Journal of Cancer, 2021

DOI 10.1002/ijc.33426 PMID 33284987 16 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Comparison of respiratory muscle strength and endurance, maximal oxygen consumption, and fatigue in colorectal cancer survivors with healthy adults

Supportive Care in Cancer, 2021

DOI 10.1007/s00520-020-05963-3 PMID 33392768 3 Zitationen (Europe PMC) Quelle: ORCID

Comparison of response and survival of first-line crizotinib therapy according to EML-4 ALK fusion variants in advanced non-small cell lung cancer patients: A Turkish Oncology Group study

Journal of B.U.ON., 2021

Quelle: ORCID

Efficacy analyses of axitinib and nivolumab in metastatic renal cell carcinoma after failure of targeted therapy: Which is better?

Journal of B.U.ON., 2021

PMID 34761618 2 Zitationen (OpenAlex) Quelle: ORCID

Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitors

Supportive Care in Cancer, 2021

DOI 10.1007/s00520-020-05702-8 PMID 32851486 10 Zitationen (Europe PMC) Quelle: ORCID

PILE: a candidate prognostic score in cancer patients treated with immunotherapy

Clinical and Translational Oncology, 2021

DOI 10.1007/s12094-021-02560-6 PMID 33586122 24 Zitationen (Europe PMC) Quelle: ORCID

Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy

Supportive Care in Cancer, 2021

DOI 10.1007/s00520-021-06139-3 PMID 33709186 20 Zitationen (Europe PMC) Quelle: ORCID

Same disease, different approaches: A report on six lymphoma cases with extranodal marginal zones in rare sites

Journal of Oncological Science, 2021

DOI 10.37047/jos.2020-79452 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

The Efficacy and Safety of Treatment Regimens Used in the First-Line Setting in Metastatic Pancreatic Cancer Patients: A Multicenter Real-Life Study

Research Square, 2021

DOI 10.21203/rs.3.rs-747492/v1 Frei zugänglicher VolltextQuelle: ORCID

The Relationship Between Systemic Immune Inflammation Index and Treatment Response in Renal Cell Carcinoma Patients Treated with Tyrosine Kinase Inhibitors: Results from The Turkish Oncology Group Kidney Cancer Consortium Database

Research Square, 2021

DOI 10.21203/rs.3.rs-1101225/v1 Frei zugänglicher VolltextQuelle: ORCID

The association between antibiotic use and survival in renal cell carcinoma patients treated with immunotherapy: a multi-center study

Current Problems in Cancer, 2021

DOI 10.1016/j.currproblcancer.2021.100760 PMID 34130864 16 Zitationen (Europe PMC) Quelle: ORCID

The association of BMI and sarcopenia with survival in patients with glioblastoma multiforme

Future Oncology, 2021

DOI 10.2217/fon-2021-0681 PMID 34409854 13 Zitationen (Europe PMC) Quelle: ORCID

The effect of the COVID-19 pandemic on routine adult vaccination in cancer patients

Medical Oncology, 2021

DOI 10.1007/s12032-021-01512-y PMID 33891205 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

The role of adjuvant chemotherapy in resected stage I non - small cell lung cancer: A Turkish Oncology Group Study

Journal of B.U.ON., 2021

Quelle: ORCID

What’s the difference between hyperprogressive disease and progressive disease for patients with treated immune checkpoint inhibitors?

Research Square, 2021

DOI 10.21203/rs.3.rs-1184111/v1 Frei zugänglicher VolltextQuelle: ORCID

456P Prognostic and predictive value of tumor-infiltrating lymphocytes in combination with systemic inflammatory markers in colon cancer

Annals of Oncology, 2021

DOI 10.1016/j.annonc.2021.08.977 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

976P The 30-day mortality rate after first cycle of immunotherapy

Annals of Oncology, 2021

DOI 10.1016/j.annonc.2021.08.1360 Frei zugänglicher VolltextQuelle: OpenAlex

Newly diagnosed cancer and the COVID-19 pandemic: tumour stage migration and higher early mortality

BMJ Supportive & Palliative Care, 2021

DOI 10.1136/bmjspcare-2021-003301 PMID 34711656 43 Zitationen (OpenAlex) Quelle: OpenAlex

MO368THE INCIDENCE AND RISK FACTORS FOR ACUTE KIDNEY INJURY IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A REAL-LIFE STUDY

Nephrology Dialysis Transplantation, 2021

DOI 10.1093/ndt/gfab082.0022 1 Zitation (OpenAlex) Quelle: OpenAlex

OA01.03 Clinical Benefits of First-Line (1L) Cemiplimab Monotherapy by PD-L1 Expression Levels in Patients With Advanced NSCLC

Journal of Thoracic Oncology, 2021

DOI 10.1016/j.jtho.2021.01.272 4 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

FP04.03 Clinical Benefit of First-Line Cemiplimab in Patients with Locally Advanced NSCLC: Subgroup Analysis from EMPOWER-Lung 1

Journal of Thoracic Oncology, 2021

DOI 10.1016/j.jtho.2021.08.217 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Physiological Cost in Daily Life Activities in Lung Cancer

European Respiratory Journal, 2021

DOI 10.1183/13993003.congress-2021.pa762 Quelle: OpenAlex

A comparison of respiratory muscle endurance, respiratory muscle endurance workload, and quality of life in low and high-fatigue colorectal cancer survivors

European Respiratory Journal, 2021

DOI 10.1183/13993003.congress-2021.pa1992 Quelle: OpenAlex

85P The association between diabetes and survival in patients treated with immunotherapy

Annals of Oncology, 2021

DOI 10.1016/j.annonc.2021.10.103 Frei zugänglicher VolltextQuelle: OpenAlex

38P The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors

Annals of Oncology, 2021

DOI 10.1016/j.annonc.2021.10.054 Frei zugänglicher VolltextQuelle: OpenAlex

Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer

Tumori Journal, 2020

DOI 10.1177/0300891620969823 PMID 33167790 4 Zitationen (Europe PMC) Quelle: OpenAlex

GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients

Lung Cancer, 2020

DOI 10.1016/j.lungcan.2020.07.022 PMID 32799090 30 Zitationen (Europe PMC) Quelle: OpenAlex

Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)

Journal of Oncology Pharmacy Practice, 2020

DOI 10.1177/1078155219900908 PMID 32054412 9 Zitationen (Europe PMC) Quelle: OpenAlex

Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey.

PubMed, 2020

PMID 33099930 5 Zitationen (Europe PMC) Quelle: OpenAlex

Third-line Therapy for Metastatic Renal Cell Carcinoma and Its Effect on Quality of Life and Overall Survival: A National, Multicenter, Observational Study

Journal of Oncological Sciences, 2020

DOI 10.37047/jos.2020-75080 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Multicenter real life expeMulticenter real life experience of biological agents in patients with metastatic colorectal cancerrience of biological agents in patients with metastatic colorectal cancer

2020

Quelle: OpenAlex

Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey

Bursa Uludag University - AVESIS, 2020

Quelle: OpenAlex

Prognostic value of the 2017 World Health Organization Classification System for gastric neuroendocrine tumors: A single-center experience

The Turkish Journal of Gastroenterology, 2020

DOI 10.5152/tjg.2020.18919 PMID 32141816 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Factors affecting the response to Y-90 microsphere therapy in the cholangiocarcinoma patients

La radiologia medica, 2020

DOI 10.1007/s11547-020-01240-9 PMID 32594427 31 Zitationen (Europe PMC) Quelle: OpenAlex

Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences

European Urology Focus, 2020

DOI 10.1016/j.euf.2020.09.010 PMID 33008789 8 Zitationen (Europe PMC) Quelle: ORCID

Clinical impact of 68Ga-DOTATATE PET-CT imaging in patients with medullary thyroid cancer

Annals of Nuclear Medicine, 2020

DOI 10.1007/s12149-020-01494-3 PMID 32602032 21 Zitationen (Europe PMC) Quelle: ORCID

Complete responses to two different anti-PD1 agents in a metastatic melanoma patient

Journal of Oncology Pharmacy Practice, 2020

DOI 10.1177/1078155219858657 PMID 31256744 3 Zitationen (Europe PMC) Quelle: ORCID

Development of de novo psoriasis during nivolumab therapy in a patient with small cell lung cancer

Journal of Oncology Pharmacy Practice, 2020

DOI 10.1177/1078155219877234 PMID 31566114 10 Zitationen (Europe PMC) Quelle: ORCID

Docetaxel, cisplatin, and fluorouracil combination chemotherapy in neoadjuvant treatment of locally advanced esophageal squamous cell carcinoma: A retrospective study

Journal of Oncological Science, 2020

DOI 10.37047/jos.2020-76836 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID